Hutchin Hill Capital’s QIAGEN NV QGENF Stock Holding History

Hutchin Hill Capital’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-23,154	Closed	-$517K	–	864
2016 Q1	$517K	Buy	+23,154	New	+$517K	0.02%	518
2015 Q3	–	Sell	-16,200	Closed	-$402K	–	903
2015 Q2	$402K	Buy	+16,200	New	+$402K	0.01%	583
2015 Q1	–	Sell	-134,200	Closed	-$3.14M	–	899
2014 Q4	$3.14M	Buy	134,200 +59,900	+81%	+$1.4M	0.11%	157
2014 Q3	$1.69M	Buy	+74,300	New	+$1.69M	0.06%	271
2014 Q2	–	Sell	-132,200	Closed	-$2.79M	–	877
2014 Q1	$2.79M	Buy	+132,200	New	+$2.79M	0.14%	105

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Hutchin Hill Capital's QGENF Position: Q2 2016 in Review

Hutchin Hill Capital sold out of QIAGEN NV (QGENF) in Q2 2016, closing a stake of 23,154 shares — an estimated $517K sold.

Hutchin Hill Capital first reported a position in QGENF in Q1 2014 and held it in 5 quarters. The position peaked at $3.14M in Q4 2014. 188 funds tracked by Wall St. Rank hold QGENF as of Q2 2016.

Hutchin Hill Capital reported no remaining QIAGEN NV position as of Q2 2016 after selling out during the quarter.
Hutchin Hill Capital sold 23,154 QIAGEN NV shares in Q2 2016, an estimated $517K.
Hutchin Hill Capital first reported a position in QIAGEN NV in Q1 2014 and held it in 5 quarters.
Hutchin Hill Capital's QIAGEN NV position peaked at $3.14M in Q4 2014.
188 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2016.

Based on Hutchin Hill Capital's 13F filing for Q2 2016, filed 15 Aug 2016.